by high-dose cyclophosphamide (HDC) and autologous stemcell transplantation. The patient's low platelet count is of concern.
... and when it is required.
o Other approach, such as allogeneicstemcelltransplant , is reasonable in some patients, but given ...

in the M-component. He received melphalan-based autologous stemcell transplantation, which was complicated by reversible respiratory ... bone narrow transplant from a donor the next step?
Allogeneic hematopoietic cell transplantation (HSCT) may be a curative ...